OncoResponse

Houston, TX · Founded 2015 · Privately Held (backing)

Developer of therapeutic antibodies designed for the treatment of cancer by probing the adaptive immune system of patients who have responded exceptionally well to checkpoint inhibition. OncoResponse is based in Houston, TX and was founded in 2015. Its last reported valuation was $36 million in May 2023. It has raised $180 million across 2 recorded rounds; the latest was a $6 million early-stage round in Apr 2025.

Last reported valuation
$36.0M
Oct 2026
Priced at
—
Total raised
$180.0M
Last round
Early Stage VC
Apr 2025
How much has OncoResponse raised?
$180.0Macross 2 recorded rounds · Aug 2018 – Apr 2025

Most recently, OncoResponse raised $6.0M in its Early Stage VC (Apr 2025).

Free account
More of OncoResponse with a free account
  • ·The complete investor list: 25 names
  • ·Watch OncoResponse: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OncoResponse round by round

2 rounds
Apr 2025Early Stage VC$6.0MSEC filing▮
9 investors participated
Aug 2018Early Stage VC$19.0MSEC filing▮
12 investors participated

How much has OncoResponse raised?

OncoResponse has raised $180 million in total; 2 of its rounds are on record. The largest on record was a $6 million early-stage round in Apr 2025.

OncoResponse has filed 2 Form Ds with the SEC since 2018, most recently in May 2025 ($6 million sold to 9 investors).

OncoResponse investors

25 investors are on record for OncoResponse, including Alexandria Venture Investments, Canaan Partners, InterVest and ARCH Venture Partners. By type, the record holds 5 venture capital firms and 2 family offices. The early-stage round in Apr 2025 drew 9 investors.

For fundraisers
Raising for a company like OncoResponse?

25 investors have backed OncoResponse.

See all 25 investors →

Frequently asked about OncoResponse

How much has OncoResponse raised?
OncoResponse has raised $180.0M in total across 2 recorded funding rounds.
When was OncoResponse's last funding round?
OncoResponse's most recent recorded round was Early Stage VC in Apr 2025, raising $6.0M.